NDC 54436-022 – Otrexup
Methotrexate 22.5 mg/.4mL · Injection, Solution · Subcutaneous
Product NDC54436-022
Product details
- Brand name
- Otrexup
- Generic name
- Methotrexate
- Labeler
- Antares Pharma, Inc.
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Marketing category
- NDA · NDA204824
- Marketed since
- October 11, 2013
- Marketing end
- April 30, 2027
- Pharmacologic class
- Folate Analog Metabolic Inhibitor
Active ingredients
- Methotrexate 22.5 mg/.4mL
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 54436-022-01 | 1 SYRINGE in 1 CARTON (54436-022-01) / .4 mL in 1 SYRINGE | Mar 24, 2016 |
| 54436-022-03 sample | 1 SYRINGE in 1 CARTON (54436-022-03) / .4 mL in 1 SYRINGE | Mar 24, 2016 |
| 54436-022-04 | 4 SYRINGE in 1 CARTON (54436-022-04) / .4 mL in 1 SYRINGE (54436-022-02) | Mar 24, 2016 |
Other Otrexup products
- 54436-010 Methotrexate 10 mg/.4mL · Injection, Solution · Antares Pharma, Inc.
- 54436-012 Methotrexate 12.5 mg/.4mL · Injection, Solution · Antares Pharma, Inc.
- 54436-015 Methotrexate 15 mg/.4mL · Injection, Solution · Antares Pharma, Inc.
- 54436-017 Methotrexate 17.5 mg/.4mL · Injection, Solution · Antares Pharma, Inc.
- 54436-020 Methotrexate 20 mg/.4mL · Injection, Solution · Antares Pharma, Inc.
- 54436-025 Methotrexate 25 mg/.4mL · Injection, Solution · Antares Pharma, Inc.